住院病人静脉输液处方的适当性:一项点流行率研究。

IF 2.6 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Barbara Sneyers, Caroline Nyssen, Pierre Bulpa, Isabelle Michaux, Dominique Lacrosse, Philippe E Dubois, Thomas Rotens, Anne Spinewine
{"title":"住院病人静脉输液处方的适当性:一项点流行率研究。","authors":"Barbara Sneyers, Caroline Nyssen, Pierre Bulpa, Isabelle Michaux, Dominique Lacrosse, Philippe E Dubois, Thomas Rotens, Anne Spinewine","doi":"10.1007/s11096-024-01816-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inappropriate use of intravenous (IV) fluids results in fluid overload, electrolyte disturbances, and increased costs.</p><p><strong>Aim: </strong>To describe IV fluid prescribing and its appropriateness in hospitalised patients.</p><p><strong>Method: </strong>A point prevalence study was conducted at two sites (academic and general) of a tertiary care hospital in Belgium. All inpatients (except those in the operating theatre) and all IV fluids prescribed during a 24-h period were analysed. Data collected included type, rate and volume administered. Each IV fluid was classified by indication (i.e., resuscitation/replacement, maintenance, catheter patency management, drug administration). Appropriateness was assessed using predefined criteria and validation by attending clinicians.</p><p><strong>Results: </strong>IV fluids were administered to 60% (297) of patients, with a median of 3 [IQR 0.5-6] IV fluid bags per patient and a median daily volume of 1000 ml [IQR 100-1550]. Amongst the 1162 IV fluid prescribed bags, 61.2% (712) were for drug administration, 22.1% (257) for catheter patency, 9.7% (112) for maintenance and 7.1% (82) for replacement/resuscitation. Inappropriate use was found for 56.9% (169) of patients with an IV fluid, representing a median volume of 300 ml per patient [IQR 10-500], and median costs of 4.60 € per patient [IQR 0.4-6.7].</p><p><strong>Conclusion: </strong>Inappropriate IV fluid use is frequent in hospitalised patients, and results in significant costs. Optimisation strategies are needed.</p>","PeriodicalId":13828,"journal":{"name":"International Journal of Clinical Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study.\",\"authors\":\"Barbara Sneyers, Caroline Nyssen, Pierre Bulpa, Isabelle Michaux, Dominique Lacrosse, Philippe E Dubois, Thomas Rotens, Anne Spinewine\",\"doi\":\"10.1007/s11096-024-01816-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Inappropriate use of intravenous (IV) fluids results in fluid overload, electrolyte disturbances, and increased costs.</p><p><strong>Aim: </strong>To describe IV fluid prescribing and its appropriateness in hospitalised patients.</p><p><strong>Method: </strong>A point prevalence study was conducted at two sites (academic and general) of a tertiary care hospital in Belgium. All inpatients (except those in the operating theatre) and all IV fluids prescribed during a 24-h period were analysed. Data collected included type, rate and volume administered. Each IV fluid was classified by indication (i.e., resuscitation/replacement, maintenance, catheter patency management, drug administration). Appropriateness was assessed using predefined criteria and validation by attending clinicians.</p><p><strong>Results: </strong>IV fluids were administered to 60% (297) of patients, with a median of 3 [IQR 0.5-6] IV fluid bags per patient and a median daily volume of 1000 ml [IQR 100-1550]. Amongst the 1162 IV fluid prescribed bags, 61.2% (712) were for drug administration, 22.1% (257) for catheter patency, 9.7% (112) for maintenance and 7.1% (82) for replacement/resuscitation. Inappropriate use was found for 56.9% (169) of patients with an IV fluid, representing a median volume of 300 ml per patient [IQR 10-500], and median costs of 4.60 € per patient [IQR 0.4-6.7].</p><p><strong>Conclusion: </strong>Inappropriate IV fluid use is frequent in hospitalised patients, and results in significant costs. Optimisation strategies are needed.</p>\",\"PeriodicalId\":13828,\"journal\":{\"name\":\"International Journal of Clinical Pharmacy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Pharmacy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11096-024-01816-9\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11096-024-01816-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:静脉输液使用不当会导致液体超负荷、电解质紊乱和费用增加:目的:描述住院病人静脉输液的处方及其适当性:方法:在比利时一家三甲医院的两个医疗点(学术医疗点和综合医疗点)开展了一项点流行病学研究。对所有住院患者(手术室患者除外)和 24 小时内开具的所有静脉输液处方进行了分析。收集的数据包括类型、输液速度和输液量。每种静脉输液均按适应症分类(即复苏/补充、维持、导管通畅管理、给药)。使用预定义的标准评估适当性,并由主治临床医生进行验证:60%(297 名)的患者接受了静脉输液,每位患者的静脉输液量中位数为 3 袋 [IQR:0.5-6],每日输液量中位数为 1000 毫升 [IQR:100-1550]。在处方的 1162 袋静脉输液中,61.2%(712 袋)用于给药,22.1%(257 袋)用于导管通畅,9.7%(112 袋)用于维持,7.1%(82 袋)用于更换/复苏。56.9%(169 名)的患者发现静脉输液使用不当,每位患者的输液量中位数为 300 毫升[IQR 10-500],每位患者的费用中位数为 4.60 欧元[IQR 0.4-6.7]:结论:住院病人静脉输液使用不当的情况时有发生,并导致高昂的费用。需要制定优化策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study.

Background: Inappropriate use of intravenous (IV) fluids results in fluid overload, electrolyte disturbances, and increased costs.

Aim: To describe IV fluid prescribing and its appropriateness in hospitalised patients.

Method: A point prevalence study was conducted at two sites (academic and general) of a tertiary care hospital in Belgium. All inpatients (except those in the operating theatre) and all IV fluids prescribed during a 24-h period were analysed. Data collected included type, rate and volume administered. Each IV fluid was classified by indication (i.e., resuscitation/replacement, maintenance, catheter patency management, drug administration). Appropriateness was assessed using predefined criteria and validation by attending clinicians.

Results: IV fluids were administered to 60% (297) of patients, with a median of 3 [IQR 0.5-6] IV fluid bags per patient and a median daily volume of 1000 ml [IQR 100-1550]. Amongst the 1162 IV fluid prescribed bags, 61.2% (712) were for drug administration, 22.1% (257) for catheter patency, 9.7% (112) for maintenance and 7.1% (82) for replacement/resuscitation. Inappropriate use was found for 56.9% (169) of patients with an IV fluid, representing a median volume of 300 ml per patient [IQR 10-500], and median costs of 4.60 € per patient [IQR 0.4-6.7].

Conclusion: Inappropriate IV fluid use is frequent in hospitalised patients, and results in significant costs. Optimisation strategies are needed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
8.30%
发文量
131
审稿时长
4-8 weeks
期刊介绍: The International Journal of Clinical Pharmacy (IJCP) offers a platform for articles on research in Clinical Pharmacy, Pharmaceutical Care and related practice-oriented subjects in the pharmaceutical sciences. IJCP is a bi-monthly, international, peer-reviewed journal that publishes original research data, new ideas and discussions on pharmacotherapy and outcome research, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics, the clinical use of medicines, medical devices and laboratory tests, information on medicines and medical devices information, pharmacy services research, medication management, other clinical aspects of pharmacy. IJCP publishes original Research articles, Review articles , Short research reports, Commentaries, book reviews, and Letters to the Editor. International Journal of Clinical Pharmacy is affiliated with the European Society of Clinical Pharmacy (ESCP). ESCP promotes practice and research in Clinical Pharmacy, especially in Europe. The general aim of the society is to advance education, practice and research in Clinical Pharmacy . Until 2010 the journal was called Pharmacy World & Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信